April 1, 2020
March 27, 2020

Cardiol Therapeutics Announces Filing of 2019 Year-End Financial Statements and MD&A

Cardiol Therapeutics Inc. filed its audited Year-end Financial Statements and Management's Discussion and Analysis for the year ended December 31,...
March 20, 2020
March 18, 2020

Cardiol Therapeutics Signs Supplier Agreement with Medical Cannabis by Shoppers, a Subsidiary of Shoppers Drug Mart Inc.

Cardiol Therapeutics Inc. has signed a supplier agreement to offer its pharmaceutically produced cannabidiol to Medical Cannabis by Shoppers.
March 5, 2020

Cardiol Therapeutics Receives Health Canada Approval for Phase 1 Study of its Pharmaceutically Produced Cannabidiol (CBD) Formulation

Cardiol Therapeutics has received a No Objection Letter from Health Canada to conduct a Phase 1 study of its pharmaceutically...
January 15, 2020

Cardiol Therapeutics’ Exclusive Manufacturing Partner Receives Three-Year Renewal and Amendment of its Cannabis Act License from Health Canada

Dalton Pharma Services, has received a three-year renewal and license amendment of its Cannabis Act Processing License from Health Canada.
January 14, 2020

Cannabidiol Offering a New Approach to Acute Myocarditis Treatment

CBD’s anti-inflammatory properties could make this cannabinoid a viable treatment for heart inflammation concerns.